Drug delivery technology developer Eitan Medical announced today that it appointed Shaul Sharoni as its new chief financial officer.
Sharoni brings more than 20 years of experience in financial management to the Netanya, Israel-based company. As CFO, his duties include overseeing all financial operations. That includes strategic financial planning, budgeting, forecasting and financial reporting.
According to a news release, Sharoni’s position plays a crucial role in managing investor relations and driving growth. He’s also responsible for ensuring the long-term success of the company in a dynamic healthcare industry.
“We are thrilled to welcome Shaul Sharoni to the Eitan Medical team,” said Shaul Eitan, CEO of Eitan Medical. “His extensive financial background and deep understanding of the medtech and digital health sectors will be invaluable as we scale our business, continue to expand our global presence and develop innovative solutions that improve patient care.”
Before joining Eitan Medical, Sharoni held a number of CFO positions across private and public organizations. His experience spans both the medical device and digital health industries.
Sharoni led a successful initial public offering at Itamar Medical and brings a proven track record of implementing effective financial strategies. The company said his specialties also include driving growth and profitability, making him “an ideal fit” for the company.
“I am honored to join Eitan Medical at such an exciting time in the company’s journey,” said Sharoni. “Eitan Medical has established itself as a leader in infusion therapy, and I look forward to contributing to its continued success by driving financial excellence and supporting its strategic objectives.”